An in vitro Model System for Evaluating Remote Magnetic Nanoparticle Movement and Fibrinolysis
Sebastian P Pernal, 1, 2 Alexander J Willis, 1 Michael E Sabo, 3 Laura M Moore, 4 Steven T Olson, 5 Sean C Morris, 4 Francis M Creighton, 3 Herbert H Engelhard 1, 2, 6 1The Cancer Center, The University of Illinois at Chicago, Chicago, IL, USA; 2Department of Neurosurgery, The University...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2020
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/abbfab1a31f64dfa98750833180d5576 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:abbfab1a31f64dfa98750833180d5576 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:abbfab1a31f64dfa98750833180d55762021-12-02T08:05:14ZAn in vitro Model System for Evaluating Remote Magnetic Nanoparticle Movement and Fibrinolysis1178-2013https://doaj.org/article/abbfab1a31f64dfa98750833180d55762020-03-01T00:00:00Zhttps://www.dovepress.com/an-in-vitro-model-system-for-evaluating-remote-magnetic-nanoparticle-m-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Sebastian P Pernal, 1, 2 Alexander J Willis, 1 Michael E Sabo, 3 Laura M Moore, 4 Steven T Olson, 5 Sean C Morris, 4 Francis M Creighton, 3 Herbert H Engelhard 1, 2, 6 1The Cancer Center, The University of Illinois at Chicago, Chicago, IL, USA; 2Department of Neurosurgery, The University of Illinois at Chicago, Chicago, IL, USA; 3UNandUP, LLC, St. Louis, MO, USA; 4Pulse Therapeutics, Inc, St. Louis, MO, USA; 5Department of Periodontics, The University of Illinois at Chicago, Chicago, IL, USA; 6Department of Bioengineering, The University of Illinois at Chicago, Chicago, IL, USACorrespondence: Herbert H EngelhardDepartment of Neurosurgery, The University of Illinois at Chicago, 912 South Wood St, Chicago, IL 60612, USATel +1 312 996-4842Email hengelhard@sbcglobal.netBackground: Thrombotic events continue to be a major cause of morbidity and mortality worldwide. Tissue plasminogen activator (tPA) is used for the treatment of acute ischemic stroke and other thrombotic disorders. Use of tPA is limited by its narrow therapeutic time window, hemorrhagic complications, and insufficient delivery to the location of the thrombus. Magnetic nanoparticles (MNPs) have been proposed for targeting tPA delivery. It would be advantageous to develop an improved in vitro model of clot formation, to screen thrombolytic therapies that could be enhanced by addition of MNPs, and to test magnetic drug targeting at human-sized distances.Methods: We utilized commercially available blood and endothelial cells to construct 1/8th inch (and larger) biomimetic vascular channels in acrylic trays. MNP clusters were moved at a distance by a rotating permanent magnet and moved along the channels by surface walking. The effect of different transport media on MNP velocity was studied using video photography. MNPs with and without tPA were analyzed to determine their velocities in the channels, and their fibrinolytic effect in wells and the trays. Results: MNP clusters could be moved through fluids including blood, at human-sized distances, down straight or branched channels, using the rotating permanent magnet. The greatest MNP velocity was closest to the magnet: 0.76 ± 0.03 cm/sec. In serum, the average MNP velocity was 0.10 ± 0.02 cm/sec. MNPs were found to enhance tPA delivery, and cause fibrinolysis in both static and dynamic studies. Fibrinolysis was observed to occur in 85% of the dynamic MNP + tPA experiments.Conclusion: MNPs hold great promise for use in augmenting delivery of tPA for the treatment of stroke and other thrombotic conditions. This model system facilitates side by side comparisons of MNP-facilitated drug delivery, at a human scale.Keywords: acute ischemic stroke, biomimetic channel, fibrinolysis, iron oxide nanoparticles, magnetic drug targeting, vascular endothelial cellsPernal SPWillis AJSabo MEMoore LMOlson STMorris SCCreighton FMEngelhard HHDove Medical Pressarticleacute ischemic strokebiomimetic channelfibrinolysisiron oxide nanoparticlesmagnetic drug targetingvascular endothelial cellsMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 1549-1568 (2020) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
acute ischemic stroke biomimetic channel fibrinolysis iron oxide nanoparticles magnetic drug targeting vascular endothelial cells Medicine (General) R5-920 |
| spellingShingle |
acute ischemic stroke biomimetic channel fibrinolysis iron oxide nanoparticles magnetic drug targeting vascular endothelial cells Medicine (General) R5-920 Pernal SP Willis AJ Sabo ME Moore LM Olson ST Morris SC Creighton FM Engelhard HH An in vitro Model System for Evaluating Remote Magnetic Nanoparticle Movement and Fibrinolysis |
| description |
Sebastian P Pernal, 1, 2 Alexander J Willis, 1 Michael E Sabo, 3 Laura M Moore, 4 Steven T Olson, 5 Sean C Morris, 4 Francis M Creighton, 3 Herbert H Engelhard 1, 2, 6 1The Cancer Center, The University of Illinois at Chicago, Chicago, IL, USA; 2Department of Neurosurgery, The University of Illinois at Chicago, Chicago, IL, USA; 3UNandUP, LLC, St. Louis, MO, USA; 4Pulse Therapeutics, Inc, St. Louis, MO, USA; 5Department of Periodontics, The University of Illinois at Chicago, Chicago, IL, USA; 6Department of Bioengineering, The University of Illinois at Chicago, Chicago, IL, USACorrespondence: Herbert H EngelhardDepartment of Neurosurgery, The University of Illinois at Chicago, 912 South Wood St, Chicago, IL 60612, USATel +1 312 996-4842Email hengelhard@sbcglobal.netBackground: Thrombotic events continue to be a major cause of morbidity and mortality worldwide. Tissue plasminogen activator (tPA) is used for the treatment of acute ischemic stroke and other thrombotic disorders. Use of tPA is limited by its narrow therapeutic time window, hemorrhagic complications, and insufficient delivery to the location of the thrombus. Magnetic nanoparticles (MNPs) have been proposed for targeting tPA delivery. It would be advantageous to develop an improved in vitro model of clot formation, to screen thrombolytic therapies that could be enhanced by addition of MNPs, and to test magnetic drug targeting at human-sized distances.Methods: We utilized commercially available blood and endothelial cells to construct 1/8th inch (and larger) biomimetic vascular channels in acrylic trays. MNP clusters were moved at a distance by a rotating permanent magnet and moved along the channels by surface walking. The effect of different transport media on MNP velocity was studied using video photography. MNPs with and without tPA were analyzed to determine their velocities in the channels, and their fibrinolytic effect in wells and the trays. Results: MNP clusters could be moved through fluids including blood, at human-sized distances, down straight or branched channels, using the rotating permanent magnet. The greatest MNP velocity was closest to the magnet: 0.76 ± 0.03 cm/sec. In serum, the average MNP velocity was 0.10 ± 0.02 cm/sec. MNPs were found to enhance tPA delivery, and cause fibrinolysis in both static and dynamic studies. Fibrinolysis was observed to occur in 85% of the dynamic MNP + tPA experiments.Conclusion: MNPs hold great promise for use in augmenting delivery of tPA for the treatment of stroke and other thrombotic conditions. This model system facilitates side by side comparisons of MNP-facilitated drug delivery, at a human scale.Keywords: acute ischemic stroke, biomimetic channel, fibrinolysis, iron oxide nanoparticles, magnetic drug targeting, vascular endothelial cells |
| format |
article |
| author |
Pernal SP Willis AJ Sabo ME Moore LM Olson ST Morris SC Creighton FM Engelhard HH |
| author_facet |
Pernal SP Willis AJ Sabo ME Moore LM Olson ST Morris SC Creighton FM Engelhard HH |
| author_sort |
Pernal SP |
| title |
An in vitro Model System for Evaluating Remote Magnetic Nanoparticle Movement and Fibrinolysis |
| title_short |
An in vitro Model System for Evaluating Remote Magnetic Nanoparticle Movement and Fibrinolysis |
| title_full |
An in vitro Model System for Evaluating Remote Magnetic Nanoparticle Movement and Fibrinolysis |
| title_fullStr |
An in vitro Model System for Evaluating Remote Magnetic Nanoparticle Movement and Fibrinolysis |
| title_full_unstemmed |
An in vitro Model System for Evaluating Remote Magnetic Nanoparticle Movement and Fibrinolysis |
| title_sort |
in vitro model system for evaluating remote magnetic nanoparticle movement and fibrinolysis |
| publisher |
Dove Medical Press |
| publishDate |
2020 |
| url |
https://doaj.org/article/abbfab1a31f64dfa98750833180d5576 |
| work_keys_str_mv |
AT pernalsp aninvitromodelsystemforevaluatingremotemagneticnanoparticlemovementandfibrinolysis AT willisaj aninvitromodelsystemforevaluatingremotemagneticnanoparticlemovementandfibrinolysis AT sabome aninvitromodelsystemforevaluatingremotemagneticnanoparticlemovementandfibrinolysis AT moorelm aninvitromodelsystemforevaluatingremotemagneticnanoparticlemovementandfibrinolysis AT olsonst aninvitromodelsystemforevaluatingremotemagneticnanoparticlemovementandfibrinolysis AT morrissc aninvitromodelsystemforevaluatingremotemagneticnanoparticlemovementandfibrinolysis AT creightonfm aninvitromodelsystemforevaluatingremotemagneticnanoparticlemovementandfibrinolysis AT engelhardhh aninvitromodelsystemforevaluatingremotemagneticnanoparticlemovementandfibrinolysis AT pernalsp invitromodelsystemforevaluatingremotemagneticnanoparticlemovementandfibrinolysis AT willisaj invitromodelsystemforevaluatingremotemagneticnanoparticlemovementandfibrinolysis AT sabome invitromodelsystemforevaluatingremotemagneticnanoparticlemovementandfibrinolysis AT moorelm invitromodelsystemforevaluatingremotemagneticnanoparticlemovementandfibrinolysis AT olsonst invitromodelsystemforevaluatingremotemagneticnanoparticlemovementandfibrinolysis AT morrissc invitromodelsystemforevaluatingremotemagneticnanoparticlemovementandfibrinolysis AT creightonfm invitromodelsystemforevaluatingremotemagneticnanoparticlemovementandfibrinolysis AT engelhardhh invitromodelsystemforevaluatingremotemagneticnanoparticlemovementandfibrinolysis |
| _version_ |
1718398678653206528 |